Latest News & Updates

EMA Announces Brexit Business Continuity Plan

In a press release issued on August 1, 2017, The European Medicines Agency (EMA) announced that it “has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom's (UK's) withdrawal from the European Union (EU) and the Agency's...

Thursday, August 3, 2017 | Read More

EU Countries Contend to Be New Host Country of the European Medicines Agency

Sentry BioPharma Services provides drug product management, global drug distribution, GMP storage and specialized services like pharmaceutical labeling, packaging and kitting.  Sentry plays a critical role in protecting temperature-sensitive product safety, identity, strength, purity and quality (SISPQ)...

Monday, July 31, 2017 | Read More

Sentry Hosts Local Congressman Hollingsworth and BIO Health Care Representatives

JULY 6, 2017 INDIANAPOLIS, IN  Sentry BioPharma Services recently hosted a round table discussion with Congressman Trey Hollingsworth (IN 9th District) and representatives of BIO and the Indiana Health Industry Forum (IHIF).  BIO organized the event as a part of its “535 Congressional Initiative 2017”. BIO...

Wednesday, July 12, 2017 | Read More

Controlled Substances

Controlled Substances: Advanced Security for Compliance and Confidence

Regulatory oversight shapes every dimension of controlled substances: licensing, registration, storage, security, use, inventory and controlled drug disposal. The DEA licenses Sentry to store, distribute, manage returns, recall and manage destruction of Schedule III-V controlled substances.  Sentry BioPharma Services provides the exacting care and management required to safeguard controlled substances which are brought into Sentry’s custody and care.  Sentry’s pharmaceutical import/export and drug product management expertise can address varying product and client needs, including packaging, distribution, storage, importation, exportation and destruction services for controlled drugs and materials.

Sentry’s culture of continuous improvement leads to consistent and reliable operations that support controlled substance product guardianship.  Redundant systems and extensive security measures assure clients that product safety, identity, strength, purity and quality (SISPQ) remain intact.  Sentry features which support this agenda include:

  • Auxiliary power feeds and back-up systems
  • Continuous (24/7) security monitoring
  • Foreign Trade Zone (FTZ) status which allows controlled substances to be internationally shipped directly to Sentry where DEA, Customs & Border Patrol (CBP) and FDA clearances can be obtained within the security provided by Sentry’s GMP facility
  • Physical plant security
  • Redundant HVAC systems
  • Secure data and document programs

For more information about how Sentry can meet safety and regulatory demands for packaging, storage, distribution and disposal of controlled drugs, contact Sentry via email or by phone at 1-866-757-7400.